How receptors respond to continuous stimulation When a GLP-1 agonist binds continuously to the receptor, the cell initiates a protective response
This rebound effect shows that the drug was working well to manage their obesity, but when they stopped using it, the weight returnedmuch like what would happen to someone with elevated blood pressure or high cholesterol
This rapid breakdown severely limits its therapeutic potential in native form
Electrolytes What are GLP-1's
The next section splits these mechanisms into two practical groups: FDA-approved GLP-1 drugs available only by prescription, such as semaglutide and tirzepatide, and non-prescription peptides that work through growth-hormone stimulation or fat-cell targeting instead, such as CJC-1295 and AOD-9604
Travel and storage: Injectables often need refrigeration and carry-on handling